NCT02955459View on ClinicalTrials.gov

VNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Bacterial Infections
Interventions
DRUG

VNRX-5133

DRUG

Placebo

Trial Locations (1)

Unknown

Lenexa

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Venatorx Pharmaceuticals, Inc.

INDUSTRY

NCT02955459 - VNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter